https://edgen.dev.edgen.tech/news/post/ubs-warns-20-tax-could-cut-hk-property-yields-to-182026-08-07T04:25:45.942Zdaily1Edgen Stocken2026-08-07T04:25:45.942+00:00UBS Warns 20% Tax Could Cut HK Property Yields to 1.8%https://static.edwealth.ai/news/images/ubs-warns-20-tax-could-cut-hk-property-yields-to-18-20260807.pngUBS Warns 20% Tax Could Cut HK Property Yields to 1.8% https://edgen.dev.edgen.tech/news/post/innodata-revenue-jumps-58-to-921m-as-ai-demand-accelerates2026-08-07T04:11:53.908Zdaily1Edgen Stocken2026-08-07T04:11:53.908+00:00Innodata revenue jumps 58% to $92.1M as AI demand accelerateshttps://static.edwealth.ai/news/images/innodata-revenue-jumps-58-to-921m-as-ai-demand-accelerates-20260807.pngInnodata revenue jumps 58% to $92.1M as AI demand accelerates https://edgen.dev.edgen.tech/news/post/irhythm-beats-q2-estimates-buys-vitalconnect-for-2875-million2026-08-07T04:11:20.118Zdaily1Edgen Stocken2026-08-07T04:11:20.118+00:00iRhythm beats Q2 estimates, buys VitalConnect for $287.5 millionhttps://static.edwealth.ai/news/images/irhythm-beats-q2-estimates-buys-vitalconnect-for-2875-million-20260807.pngiRhythm beats Q2 estimates, buys VitalConnect for $287.5 million https://edgen.dev.edgen.tech/news/post/alphabet-reshuffles-ai-leadership-as-hassabis-steps-back-shares-fall-52026-08-07T04:08:08.711Zdaily1Edgen Stocken2026-08-07T04:08:08.711+00:00Alphabet reshuffles AI leadership as Hassabis steps back, shares fall 5%https://static.edwealth.ai/news/images/alphabet-reshuffles-ai-leadership-as-hassabis-steps-back-shares-fall-5-20260807.pngAlphabet reshuffles AI leadership as Hassabis steps back, shares fall 5% https://edgen.dev.edgen.tech/news/post/anthropics-1-trillion-ipo-tests-amodeis-safety-first-paradox2026-08-07T04:06:43.953Zdaily1Edgen Stocken2026-08-07T04:06:43.953+00:00Anthropic's $1 trillion IPO tests Amodei's safety-first paradoxhttps://static.edwealth.ai/news/images/anthropics-1-trillion-ipo-tests-amodeis-safety-first-paradox-20260807.pngAnthropic's $1 trillion IPO tests Amodei's safety-first paradox https://edgen.dev.edgen.tech/news/post/july-payrolls-test-feds-50-50-september-hike-as-adp-misses2026-08-07T04:04:19.447Zdaily1Edgen Stocken2026-08-07T04:04:19.447+00:00July Payrolls Test Fed's 50-50 September Hike as ADP Misseshttps://static.edwealth.ai/news/images/july-payrolls-test-feds-50-50-september-hike-as-adp-misses-20260807.pngJuly Payrolls Test Fed's 50-50 September Hike as ADP Misses https://edgen.dev.edgen.tech/news/post/silver-jumps-83-as-dollar-slide-triggers-cta-short-covering2026-08-07T04:03:59.051Zdaily1Edgen Stocken2026-08-07T04:03:59.051+00:00Silver jumps 8.3% as dollar slide triggers CTA short coveringhttps://static.edwealth.ai/news/images/silver-jumps-83-as-dollar-slide-triggers-cta-short-covering-20260807.pngSilver jumps 8.3% as dollar slide triggers CTA short covering https://edgen.dev.edgen.tech/news/post/chinas-capital-goods-exports-jump-25-as-trade-engine-shifts-upmarket2026-08-07T04:02:14.053Zdaily1Edgen Stocken2026-08-07T04:02:14.053+00:00China's Capital Goods Exports Jump 25% as Trade Engine Shifts Upmarkethttps://static.edwealth.ai/news/images/chinas-capital-goods-exports-jump-25-as-trade-engine-shifts-upmarket-20260807.pngChina's Capital Goods Exports Jump 25% as Trade Engine Shifts Upmarket https://edgen.dev.edgen.tech/news/post/naver-q2-net-profit-jumps-416-as-ai-boosts-core-businesses2026-08-07T03:59:36.322Zdaily1Edgen Stocken2026-08-07T03:59:36.322+00:00Naver Q2 net profit jumps 41.6% as AI boosts core businesseshttps://static.edwealth.ai/news/images/naver-q2-net-profit-jumps-416-as-ai-boosts-core-businesses-20260807.pngNaver Q2 net profit jumps 41.6% as AI boosts core businesses https://edgen.dev.edgen.tech/news/post/china-july-exports-rise-239-as-ai-chip-demand-offsets-slowdown2026-08-07T03:56:19.446Zdaily1Edgen Stocken2026-08-07T03:56:19.446+00:00China July exports rise 23.9% as AI chip demand offsets slowdownhttps://static.edwealth.ai/news/images/china-july-exports-rise-239-as-ai-chip-demand-offsets-slowdown-20260807.pngChina July exports rise 23.9% as AI chip demand offsets slowdown https://edgen.dev.edgen.tech/news/post/china-july-exports-cool-to-178-as-tariff-frontloading-fades2026-08-07T03:54:23.650Zdaily1Edgen Stocken2026-08-07T03:54:23.650+00:00China July exports cool to 17.8% as tariff frontloading fadeshttps://static.edwealth.ai/news/images/china-july-exports-cool-to-178-as-tariff-frontloading-fades-20260807.pngChina July exports cool to 17.8% as tariff frontloading fades https://edgen.dev.edgen.tech/news/post/chinas-july-trade-surplus-shrinks-92-billion-yuan-as-imports-cool2026-08-07T03:50:43.855Zdaily1Edgen Stocken2026-08-07T03:50:43.855+00:00China's July trade surplus shrinks 92 billion yuan as imports coolhttps://static.edwealth.ai/news/images/chinas-july-trade-surplus-shrinks-92-billion-yuan-as-imports-cool-20260807.pngChina's July trade surplus shrinks 92 billion yuan as imports cool https://edgen.dev.edgen.tech/news/post/perps-target-us-stocks-as-cme-launches-50-single-stock-futures2026-08-07T03:48:14.757Zdaily1Edgen Stocken2026-08-07T03:48:14.757+00:00Perps target US stocks as CME launches 50 single-stock futureshttps://static.edwealth.ai/news/images/perps-target-us-stocks-as-cme-launches-50-single-stock-futures-20260807.pngPerps target US stocks as CME launches 50 single-stock futures https://edgen.dev.edgen.tech/news/post/eight-polysilicon-giants-pledge-cost-floor-pricing-as-shares-jump-852026-08-07T03:44:52.517Zdaily1Edgen Stocken2026-08-07T03:44:52.517+00:00Eight polysilicon giants pledge cost-floor pricing as shares jump 8.5%https://static.edwealth.ai/news/images/eight-polysilicon-giants-pledge-cost-floor-pricing-as-shares-jump-85-20260807.pngEight polysilicon giants pledge cost-floor pricing as shares jump 8.5% https://edgen.dev.edgen.tech/news/post/spacex-shares-climb-61-as-lockup-releases-912-million-shares2026-08-07T03:39:02.304Zdaily1Edgen Stocken2026-08-07T03:39:02.304+00:00SpaceX shares climb 6.1% as lockup releases 912 million shareshttps://static.edwealth.ai/news/images/spacex-shares-climb-61-as-lockup-releases-912-million-shares-20260807.pngSpaceX shares climb 6.1% as lockup releases 912 million shares https://edgen.dev.edgen.tech/news/post/transthera-shares-jump-14-on-china-approval-of-tinengotinib2026-08-07T03:35:06.634Zdaily1Edgen Stocken2026-08-07T03:35:06.634+00:00TransThera shares jump 14% on China approval of tinengotinibhttps://static.edwealth.ai/news/images/transthera-shares-jump-14-on-china-approval-of-tinengotinib-20260807.pngTransThera shares jump 14% on China approval of tinengotinib https://edgen.dev.edgen.tech/news/post/ai-creates-16-new-viruses-as-biosecurity-concerns-mount2026-08-07T03:30:56.848Zdaily1Edgen Stocken2026-08-07T03:30:56.848+00:00AI creates 16 new viruses as biosecurity concerns mounthttps://static.edwealth.ai/news/images/ai-creates-16-new-viruses-as-biosecurity-concerns-mount-20260807.pngAI creates 16 new viruses as biosecurity concerns mount https://edgen.dev.edgen.tech/news/post/canada-services-pmi-stays-in-contraction-as-costs-hit-35-year-high2026-08-07T03:28:49.452Zdaily1Edgen Stocken2026-08-07T03:28:49.452+00:00Canada Services PMI Stays in Contraction as Costs Hit 3.5-Year Highhttps://static.edwealth.ai/news/images/canada-services-pmi-stays-in-contraction-as-costs-hit-35-year-high-20260807.pngCanada Services PMI Stays in Contraction as Costs Hit 3.5-Year High https://edgen.dev.edgen.tech/news/post/lumilens-raises-700-million-to-replace-data-center-copper-with-light2026-08-07T03:26:47.055Zdaily1Edgen Stocken2026-08-07T03:26:47.055+00:00Lumilens raises $700 million to replace data-center copper with lighthttps://static.edwealth.ai/news/images/lumilens-raises-700-million-to-replace-data-center-copper-with-light-20260807.pngLumilens raises $700 million to replace data-center copper with light https://edgen.dev.edgen.tech/news/post/fda-approves-replimunes-tudriqev-melanoma-drug-after-two-rejections2026-08-07T03:25:18.127Zdaily1Edgen Stocken2026-08-07T03:25:18.127+00:00FDA approves Replimune's Tudriqev melanoma drug after two rejectionshttps://static.edwealth.ai/news/images/fda-approves-replimunes-tudriqev-melanoma-drug-after-two-rejections-20260807.pngFDA approves Replimune's Tudriqev melanoma drug after two rejections